Anna Segerman
Impact in
Papers in
-
- Viral Infectious Diseases and Gene Expression in Insects 5
- Single-cell and spatial transcriptomics 2
- Genetics 7
- Virus-based gene therapy research 7
- Glioma Diagnosis and Treatment 3
- Co-authors
- Göran Wadell (7 shared papers)Niklas Arnberg (2 shared papers)Marko Marttila (1 shared paper)John P. Atkinson (1 shared paper)Ya-Fang Mei (5 shared papers)Kristina Lindman (5 shared papers)Bengt Westermark (7 shared papers)Mia Niklasson (9 shared papers)
- Journals
- Journal of Virology (5 papers)Virology (2 papers)BMC Bioinformatics (2 papers)Cancer Research (2 papers)Scientific Reports (1 paper)
- Partner nations
- SwedenUnited StatesCanada
In The Last Decade
Anna Segerman
17 papers receiving 750 citations
Peers
Comparison fields: 5 of 66
- Genetics 441
- Oncology 235
- Infectious Diseases 135
- Molecular Biology 471
- Biophysics 35
Countries citing papers authored by Anna Segerman
This map shows the geographic impact of Anna Segerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Segerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Segerman more than expected).
Fields of papers citing papers by Anna Segerman
This network shows the impact of papers produced by Anna Segerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Segerman. The network helps show where Anna Segerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Segerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 292 | |
| 2 | 2015 | 168 | |
| 3 | 2002 | 79 | |
| 4 | 2000 | 70 | |
| 5 | 2019 | 32 | |
| 6 | 2021 | 30 | |
| 7 | 2006 | 27 | |
| 8 | 2014 | 24 | |
| 9 | 2004 | 14 | |
| 10 | 2006 | 11 | |
| 11 | 2024 | 7 | |
| 12 | 2019 | 3 | |
| 13 | 2018 | 3 | |
| 14 | 2019 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2006 | 1 | |
| 17 | 2017 | 1 |
About Anna Segerman
Anna Segerman is a scholar working on Molecular Biology, Genetics, Oncology, Genetics and Infectious Diseases, having authored 17 papers that have together received 767 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), CAR-T cell therapy research (5 papers), Glioma Diagnosis and Treatment (3 papers), Single-cell and spatial transcriptomics (2 papers), Viral Infections and Immunology Research (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Genetics (441 citations), Oncology (235 citations), Infectious Diseases (135 citations), Molecular Biology (471 citations) and Biophysics (35 citations). Anna Segerman has collaborated with scholars based in Sweden, United States and Canada. Frequent co-authors include Göran Wadell, Niklas Arnberg, Marko Marttila, John P. Atkinson, Ya-Fang Mei, Kristina Lindman, Bengt Westermark, Mia Niklasson, Sven Nelander and Voichita D. Marinescu. Their work appears in journals such as Journal of Virology, Virology, BMC Bioinformatics, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.